Antiretroviral therapy coverage for PMTCT in Cuba
Cuba: Antiretroviral therapy coverage for PMTCT was 89.0% in 2024. ▲ Rising
Antiretroviral therapy coverage for PMTCT in Cuba, 2000–2024
Source: UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Measured in % of pregnant women living with HIV.
Analysis
Cuba recorded 89.0% for antiretroviral therapy coverage for pmtct in 2024.
That represents a change of down 11.0% on the previous year and up 64.8% over ten years.
Over the whole period, antiretroviral therapy coverage for pmtct in Cuba peaked at 100.0% in 2020 and was at its lowest, 0.0%, in 2000.
Cuba ranks 30th of 84 countries on this measure, in the middle of the range.
The long-run direction has been consistently rising across the 25 years of available data.
Antiretroviral therapy coverage for PMTCT in Cuba, year by year
| Year | % of pregnant women living with HIV | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 58.0% | — |
| 2002 | 26.0% | -55.2% |
| 2003 | 23.0% | -11.5% |
| 2004 | 32.0% | +39.1% |
| 2005 | 43.0% | +34.4% |
| 2006 | 60.0% | +39.5% |
| 2007 | 40.0% | -33.3% |
| 2008 | 42.0% | +5.0% |
| 2009 | 40.0% | -4.8% |
| 2010 | 47.0% | +17.5% |
| 2011 | 75.0% | +59.6% |
| 2012 | 70.0% | -6.7% |
| 2013 | 62.0% | -11.4% |
| 2014 | 54.0% | -12.9% |
| 2015 | 83.0% | +53.7% |
| 2016 | 77.0% | -7.2% |
| 2017 | 80.0% | +3.9% |
| 2018 | 94.0% | +17.5% |
| 2019 | 97.0% | +3.2% |
| 2020 | 100.0% | +3.1% |
| 2021 | 99.0% | -1.0% |
| 2022 | 100.0% | +1.0% |
| 2023 | 100.0% | +0.0% |
| 2024 | 89.0% | -11.0% |
Cuba compared with similar countries
- Cuba's 89.0% is above the median for upper middle income countries, which is 79.5%, 1.1× the median. (22 countries reporting)
- Cuba's 89.0% is above the median for Latin America & Caribbean, which is 68.0%, 1.3× the median. (15 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 36.4% | 0.0% | 60.0% | 10 |
| 2010s | 73.9% | 47.0% | 97.0% | 10 |
| 2020s | 97.6% | 89.0% | 100.0% | 5 |
Countries ranked near Cuba
More health data for Cuba
- Un projection of annual infant deaths, annual growth rate -1.47 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.2059 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,696 deaths per 1,000 people (2090)
- Number of infants who die before age 1 67 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -2.62 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2020)
- Population ages 00-04, female, per capita 0.021 units per person (2025)
- Population ages 00-04, male, annual growth rate -2.64 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2020)
Frequently asked questions
- What is antiretroviral therapy coverage for pmtct in Cuba?
- Antiretroviral therapy coverage for pmtct in Cuba was 89.0% in 2024, according to UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS).
- What is the highest antiretroviral therapy coverage for pmtct recorded in Cuba?
- The highest recorded value was 100.0% in 2020.
- What is the lowest antiretroviral therapy coverage for pmtct recorded in Cuba?
- The lowest recorded value was 0.0% in 2000.
- How does Cuba rank for antiretroviral therapy coverage for pmtct?
- Cuba ranks 30th out of 84 countries with data for 2024.
- Is antiretroviral therapy coverage for pmtct rising or falling in Cuba?
- Over the last ten years it is up 64.8%. The long-run trend across the full record is rising.
- Where does this Cuba data come from?
- The figures come from UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as part of Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).